Half- Dose Recombinant Tissue Plasminogen Activator Treatment in Venous Thromboembolism

HASANOĞLU, HATİCE; Hezer, Habibe; Karalezli, Aysegul; Arguder, Emine; Kilic, Hatice; Senturk, Aysegul; Er, Mukremin; Noyturk, Ayse

Half- Dose Recombinant Tissue Plasminogen Activator Treatment in Venous Thromboembolism

Atıf İçin Kopyala

HASANOĞLU H. C. , Hezer H., Karalezli A., Arguder E., Kilic H., Senturk A., et al.

JOURNAL OF INVESTIGATIVE MEDICINE, cilt.62, ss.71-77, 2014 (SCI İndekslerine Giren Dergi)

Cilt numarası: 62 Konu: 1
Basım Tarihi: 2014
Dergi Adı: JOURNAL OF INVESTIGATIVE MEDICINE
Sayfa Sayısı: ss.71-77

Özet

Background Adrenomedullin (AM) is a vasodilator peptide produced by endothelial and smooth muscle cells in the systemic and pulmonary circulation. It promotes angiogenesis and alveolar growth and has protective effects in the cardiovascular and respiratory systems. Adrenomedullin's role in human pulmonary vascular and alveolar development is unknown.